Skip to content
Alivexis, Inc.
Unveiling the Future of Medicine
Menu
Home
Science
Pipeline
About Us
News
Public Notice
Contact Us
日本語
News
News
40th Annual J.P. Morgan Healthcare Conference － Modulus Discovery Presentation
- 14 January, 2022
Nissan Chemical and Modulus Discovery Jointly Announce Signing of Strategic Drug Discovery Collaboration Agreement
- 21 April, 2021
39th Annual J.P. Morgan Healthcare Conference － Modulus Discovery Presentation
- 26 January, 2021
Modulus Discovery, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
- 14 December, 2020
Modulus Discovery Announces Signing of a Collaboration Agreement with the University Of Tokyo to Pursue Drug Discovery for COVID-19 and Related Emerging Virus Infections
- 02 October, 2020
Modulus Discovery Receives “Mizuho Innovation Award”
- 28 July, 2020
Modulus Discovery Closes $25.5M USD Series B
- 13 May, 2020
Modulus Discovery Announces Signing of Research Data Transfer Agreement with Astellas Pharma Inc.
- 30 May, 2019
Modulus Discovery Announces Signing of Collaboration Agreement with Tokyo Institute of Technology
- 09 May, 2019
Modulus Discovery Announces Senior Appointments including Jon Mason as Scientific Advisor
- 28 January, 2019
Previous
Next
Press & Media Contact
Email address protected by JavaScript.
Please enable JavaScript to contact me.
Latest Release
Alivexis Announces Receipt of Intention to Exercise Option Right from Astellas Pharma Inc. for Collaboration on Novel Drug Target
Notice of Selection for the Ministry of Economy, Trade and Industry’s Domestic Generative AI Development Strengthening Project “GENIAC”
Alivexis to Present at the 2025 BIO International Convention
Alivexis To Present at GTC 2025 Japan AI Day
Alivexis Raises $0.7M USD Series D in Second Close
